Australia markets closed

Leap Therapeutics, Inc. (LPTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2500+0.0800 (+2.52%)
At close: 04:00PM EDT
3.2000 -0.05 (-1.54%)
After hours: 06:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 83.21M
Enterprise value 12.83M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)160.10
Price/book (mrq)1.38
Enterprise value/revenue -66.81
Enterprise value/EBITDA -0.16

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3-18.75%
S&P500 52-week change 322.36%
52-week high 310.2000
52-week low 31.2350
50-day moving average 32.7706
200-day moving average 32.5133

Share statistics

Avg vol (3-month) 3322.28k
Avg vol (10-day) 3235.49k
Shares outstanding 525.6M
Implied shares outstanding 625.6M
Float 819.45M
% held by insiders 115.88%
% held by institutions 125.16%
Shares short (15 Apr 2024) 41.45M
Short ratio (15 Apr 2024) 42.75
Short % of float (15 Apr 2024) 45.84%
Short % of shares outstanding (15 Apr 2024) 45.67%
Shares short (prior month 15 Mar 2024) 41.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 321 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-75.03%
Return on equity (ttm)-136.82%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -85.92M
Net income avi to common (ttm)-81.41M
Diluted EPS (ttm)-3.9800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)70.64M
Total cash per share (mrq)2.76
Total debt (mrq)262k
Total debt/equity (mrq)0.44%
Current ratio (mrq)5.64
Book value per share (mrq)2.35

Cash flow statement

Operating cash flow (ttm)-43.75M
Levered free cash flow (ttm)-46.85M